• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Broad Agency Announcement (BAA)

Description: The BAA outlines research areas of interest that will help fulfill the FDA requirements to utilize capabilities for state of the art advancement and achieve improvements in technology, materials, processes, methods, devices, or techniques in specific topics. The BAA runs for a period of 1 year and solicits proposals that focus on the following areas of interest: toxicology, personalized medicine, improve manufacturing and quality,emerging technologies, harnessing data, food safety, medical countermeasures.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Publish BAA

5/23/2012

Completed 5/23/2012

B. Train First Review Committee

6/25/2012

Completed 6/25/2012

C. Convene First Review Committee

7/12/2012

Completed 7/12/2012

D. Award Contracts

3/31/2011

Completed 12/5/2010

E. Begin additional training (training is ongoing)

11/30/2012

(5/31/2013)

Completed 5/23/2013

F. Amend and Renew BAA

5/31/2013

Completed 5/23/2013

G. Hold BAA proposal conference

6/30/2013

Completed 3/25/2013

H. Complete 4th quarter white paper reviews

7/31/2013

Completed 7/16/2013

Footnotes

  • The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.